SAMHD1 and cancer: In a similar fashion, RNR inhibition leads to apparent indirect inactivation of SAMHD1 drug resistance activity, probably owing to imbalances in dNTP levels and perturbation of SAMHD1 allosteric regulation, highlighting their tight interconnection, which can be exploited for cancer therapy (Rudd et al., 2020).